Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olga P. Rogozina is active.

Publication


Featured researches published by Olga P. Rogozina.


Cancer and Metastasis Reviews | 2010

Obesity and breast cancer: status of leptin and adiponectin in pathological processes

Michael E. Grossmann; Amitabha Ray; Katai J. Nkhata; Dmitry Malakhov; Olga P. Rogozina; Soner Dogan; Margot P. Cleary

It is well recognized that obesity increases the risk of various cancers, including breast malignancies in postmenopausal women. Furthermore, obesity may adversely affect tumor progression, metastasis, and overall prognosis in both pre- and postmenopausal women with breast cancer. However, the precise mechanism(s) through which obesity acts is/are still elusive and this relationship has been the subject of much investigation and speculation. Recently, adipose tissue and its associated cytokine-like proteins, adipokines, particularly leptin and adiponectin, have been investigated as mediators for the association of obesity with breast cancer. Higher circulating levels of leptin found in obese subjects could be a growth-enhancing factor as supported by in vitro and preclinical studies, whereas low adiponectin levels in obese women may be permissive for leptin’s growth-promoting effects. These speculations are supported by in vitro studies which indicate that leptin promotes human breast cancer cell proliferation while adiponectin exhibits anti-proliferative actions. Further, estrogen and its receptors have a definite impact on the response of human breast cancer cell lines to leptin and adiponectin. More in-depth studies are needed to provide additional and precise links between the in vivo development of breast cancer and the balance of adiponectin and leptin.


Nutrition and Cancer | 2009

Intermittent Calorie Restriction Delays Prostate Tumor Detection and Increases Survival Time in TRAMP Mice

Melissa J.L. Bonorden; Olga P. Rogozina; Christina M. Kluczny; Michael E. Grossmann; Patricia L. Grambsch; Joseph P. Grande; Susan N. Perkins; Anna Lokshin; Margot P. Cleary

Prostate cancer is the most frequently diagnosed cancer in men. Whereas chronic calorie restriction (CCR) delays prostate tumorigenesis in some rodent models, the impact of intermittent caloric restriction (ICR) has not been determined. Here, transgenic adenocarcinoma of the mouse prostate (TRAMP) mice were used to compare how ICR and CCR affected prostate cancer development. TRAMP mice were assigned to ad libitum (AL), ICR (2 wk 50% AL consumption followed by 2 wk pair feeding to AL consumption), and CCR (25% AL consumption) groups at 7 wk of age and followed until disease burden necessitated euthanasia or mice reached terminal endpoints (48 or 50 wk of age). Body weights fluctuated in response to calorie intake (P < 0.0001). ICR mice were older at tumor detection than AL (P = 0.0066) and CCR (P = 0.0416) mice. There was no difference for age of tumor detection between AL and CCR mice (P = 0.3960). Similar results were found for survival. Serum leptin, adiponectin, insulin, and IGF-I were all significantly different among the groups. These results indicate that the way in which calories are restricted impacts both time to tumor detection and survival in TRAMP mice, with ICR providing greater protective effect compared to CCR.


Cancer Prevention Research | 2011

Effect of Chronic and Intermittent Calorie Restriction on Serum Adiponectin and Leptin and Mammary Tumorigenesis

Olga P. Rogozina; Melissa J.L. Bonorden; Christine N. Seppanen; Joseph P. Grande; Margot P. Cleary

The effect of chronic (CCR) and intermittent (ICR) caloric restriction on serum adiponectin and leptin levels was investigated in relation to mammary tumorigenesis. 10-wks old MMTV-TGF-α female mice were assigned to ad libitum fed (AL; AIN-93M diet), ICR (3-week 50% caloric restriction, AIN-93M-mod diet, 2× protein, fat, vitamins, and minerals followed by 3-wks 100% AL consumption of AIN-93M), and CCR (calorie and nutrient intake matched for each 6-wks ICR cycle, ∼75% of AL) groups. Mice were sacrificed at 79 (end of restriction) or 82 (end of refeeding) wks of age. Serum was obtained in cycles 1, 3, 5, 8, 11, and terminal. Mammary tumor incidence was 71.0%, 35.4%, and 9.1% for AL, CCR, and ICR mice, respectively. Serum adiponectin levels were similar among groups with no impact of either CCR or ICR. Serum leptin level rose in AL mice with increasing age but was significantly reduced by long-term CCR and ICR. The ICR protocol was also associated with an elevated adiponectin/leptin ratio. In addition, ICR-restricted mice had increased mammary tissue AdipoR1 expression and decreased leptin and ObRb expression compared with AL mice. Mammary fat pads from tumor-free ICR-mice had higher adiponectin expression than AL and CCR mice whereas all tumor-bearing mice had weak adiponectin signal in mammary fat pad. Although we did not show an association of either adiponectin or leptin with individual mice in relation to mammary tumorigenesis, we did find that reduced serum leptin and elevated adiponectin/leptin ratio were associated with the protective effect of intermittent calorie restriction. Cancer Prev Res; 4(4); 568–81. ©2011 AACR.


The Prostate | 2009

Cross-sectional analysis of intermittent versus chronic caloric restriction in the TRAMP mouse

Melissa J.L. Bonorden; Olga P. Rogozina; Christina M. Kluczny; Michael E. Grossmann; Joseph P. Grande; Anna Lokshin; Margot P. Cleary

Previously we found that intermittent calorie restriction (ICR) delayed the age of prostate tumor detection and death in TRAMP mice in comparison to chronic calorie restricted (CCR) and ad libitum fed (AL) TRAMP mice.


Cancer Prevention Research | 2009

Serum Insulin-like Growth Factor-I and Mammary Tumor Development in Ad libitum-Fed, Chronic Calorie-Restricted, and Intermittent Calorie-Restricted MMTV-TGF-α Mice

Olga P. Rogozina; Melissa J.L. Bonorden; Joseph P. Grande; Margot P. Cleary

The effect of chronic (CCR) and intermittent (ICR) caloric restriction on serum insulin-like growth factor (IGF)-I levels and mammary tumor (MT) development was investigated. Ten-week-old MMTV-TGF-α female mice were assigned to ad libitum–fed (AL; AIN-93M diet), ICR [3-week 50% caloric restriction using AIN-93M-mod diet, 2× protein, fat, vitamins, and minerals followed by 3 weeks of daily 100% AL consumption of AIN-93M (∼75% of AL for each 6-week cycle)], and CCR (calorie and nutrient intake matched for each 6-week ICR cycle) groups. Half of the mice from each group were sacrificed at 79 (end of restriction) or 82 (end of refeeding) weeks of age. Serum was obtained at euthanasia and in cycles 1, 3, 5, 8, and 11. MT incidence was 71.0%, 35.4%, and 9.1% for AL, CCR, and ICR mice. ICR-Restricted mice had significantly lower terminal serum IGF-I and IGF-I/IGF binding protein-3 (IGFBP-3) ratio than CCR, ICR-Refed, and AL mice. There were no differences in terminal IGFBP-3. Final body, internal, and mammary fat pad weights correlated positively with IGF-I and negatively with IGFBP-3. Few changes were found for protein expression of IGF-IRα and IGFBP-3 in mammary tissue and MTs. During the study, IGF-I levels of ICR-Restricted mice were reduced, whereas refeeding allowed partial recovery. For all groups, elevated IGF-I levels preceded MT detection, although not all values were significant versus mice without MTs. However, the specific role of IGF-I in the protective effect of calorie restriction remains to be determined. These results confirm that ICR prevents MT development to a greater extent than CCR.


Cancer Prevention Research | 2013

Combination of Intermittent Calorie Restriction and Eicosapentaenoic Acid for Inhibition of Mammary Tumors

Nancy K. Mizuno; Olga P. Rogozina; Christine M. Seppanen; D. Joshua Liao; Margot P. Cleary; Michael E. Grossmann

There are a number of dietary interventions capable of inhibiting mammary tumorigenesis; however, the effectiveness of dietary combinations is largely unexplored. Here, we combined 2 interventions previously shown individually to inhibit mammary tumor development. The first was the use of the omega-3 fatty acid, eicosapentaenoic acid (EPA), and the second was the implementation of calorie restriction. MMTV-Her2/neu mice were used as a model for human breast cancers, which overexpress Her2/neu. Six groups of mice were enrolled. Half were fed a control (Con) diet with 10.1% fat calories from soy oil, whereas the other half consumed a diet with 72% fat calories from EPA. Within each diet, mice were further divided into ad libitum (AL), chronic calorie-restricted (CCR), or intermittent calorie-restricted (ICR) groups. Mammary tumor incidence was lowest in ICR-EPA (15%) and highest in AL-Con mice (87%), whereas AL-EPA, CCR-Con, CCR-EPA, and ICR-Con groups had mammary tumor incidence rates of 63%, 47%, 40%, and 59%, respectively. Survival was effected similarly by the interventions. Consumption of EPA dramatically reduced serum leptin (P < 0.02) and increased serum adiponectin in the AL-EPA mice compared with AL-Con mice (P < 0.001). Both CCR and ICR decreased serum leptin and insulin-like growth factor I (IGF-I) compared with AL mice but not compared with each other. These results illustrate that mammary tumor inhibition is significantly increased when ICR and EPA are combined as compared with either intervention alone. This response may be related to alterations in the balance of serum growth factors and adipokines. Cancer Prev Res; 6(6); 540–7. ©2013 AACR.


Cancer Research | 2012

Abstract 597: Response of reactive oxygen species to eicosapentaenoic and calorie restriction in relation to mammary tumor prevention

Christine M. Seppanen; Sarah J. Ewing; Nancy K. Mizuno; Olga P. Rogozina; Margot P. Cleary; D. Joshua Liao; Michael E. Grossman

Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Exposure of lipid biomembranes to reactive oxygen species (ROS) results in the generation of a wide variety of lipid peroxidation products. Some of these products, including 4-hydroxy-2-nonenal (4HNE) can form protein adducts which may impact pathways associated with tumorigenesis. We have reported that calorie restriction protects against spontaneous mammary tumor development in mice and have recently shown that this is accompanied by a decrease in serum levels of lipid peroxidation products. Eicosapentaenoic acid (EPA) is known to inhibit mammary tumorigenesis; however, this type of highly unsaturated omega-3 fatty acid has also been shown to increase in vivo levels of lipid peroxidation products. In the present study, the interaction of calorie restriction and dietary EPA was investigated with respect to mammary tumor formation. Lipid peroxidation products of ROS were also measured. From 10 weeks of age MMTV-Her2/neu mice were fed a modified AIN-93M diet (10.2% kcal from fat) which had either 100% soybean oil (SO) as the fat source or a blend of EPA (72%) and SO (18%). Mice were further divided into groups which were ad libitum-fed, (AL); chronic calorie restricted (CCR, received 75% of AL) or intermittently calorie restricted (ICR, received 50% of AL for 3 weeks followed by 3 weeks at 100% of AL) until 60 weeks of age or until mammary tumor size required euthanasia. Mice were weighed and examined for mammary tumors weekly. Serum thiobarbituric acid reactive substances (TBARS) and 4-hydroxy-2-nonenal (4HNE)-protein adducts in mammary tissues were measured to assess the extent of lipid peroxidation. In both diet groups, mammary tumor incidence was highest in the AL group (SO 87%, EPA 63%). These groups also had the highest levels of serum TBARS and the AL-SO group had the highest level of mammary tissue 4HNE-protein adducts. The calorie restricted mice had lower levels of mammary tumor incidence (CCR-SO 47%, CCR-EPA 40%, ICR-SO 59%) with the lowest level in the ICR-EPA group (15%). The ICR-SO group had serum TBARS and mammary tissue 4HNE-protein adduct levels that were significantly lower than the AL-SO group (p<0.05 for both). In the EPA groups, there was no difference between the AL, CCR, and ICR groups in either serum TBARS or mammary tissue 4HNE-protein adducts. These results suggest that higher levels of lipid peroxidation products are associated with a higher incidence of mammary tumors. However, although the dietary combination of ICR and EPA resulted in the greatest amount of mammary tumor inhibition, this combination was not associated with the lowest level of lipid peroxidation products. The relationship between EPA, calorie restriction, and reactive oxygen species appears to be quite complex. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 597. doi:1538-7445.AM2012-597


Cancer Prevention Research | 2010

Abstract B63: Combination of intermittent calorie restriction and eicosapentaenoic acid for inhibition of mammary tumors

Nancy K. Mizuno; Olga P. Rogozina; Christine M. Seppanen; D. Joshua Liao; Margot P. Cleary; Michael E. Grossmann

Introduction: Nutrition can have a profound effect on breast cancer inhibition and growth. We have focused on two dietary interventions that separately prevent mammary tumorigenesis, eicosapentaenoic acid (EPA), an ω-3 fatty acid, and intermittent calorie restriction (ICR), as we recently reported that multiple periods of intermittent caloric restriction (ICR) were superior for inhibition of mammary tumor (MT) formation compared to chronic calorie restriction. Here we assessed whether combining two interventions, EPA consumption and ICR, would achieve even greater inhibition of breast cancer formation than either alone. Methods: Four groups of MMTV-HER-2/neu transgenic mice that are genetically programmed to develop mammary tumors were utilized. From 10 weeks of age half of the mice were fed a diet with fat derived from soy oil and the other half consumed a diet with 71.75% of fat calories from EPA. Mice were further divided into ad libitum (AL) or intermittent caloric restricted (ICR) groups. AL groups (soy oil and EPA) received unrestricted access to their diets. ICR groups were fed calories equal to 100% of the AL age-matched groups for three weeks followed by three weeks of calories equal to 50% of the AL age-matched groups. Mice were weighed weekly and carefully examined for mammary tumors. The 6 week cycle of restriction/refeeding was maintained until the mice were 55 weeks or were euthanized due to MTs. Results: The Ad Lib Soy and Ad Lib EPA groups ate similar amounts and gained weight at similar rates. The body weights of the ICR Soy and ICR EPA groups were not significantly different from each other but were significantly lower than the Ad Lib mice. The tumor free period was shortest in the AL Soy with increasingly long tumor free periods for the Ad Lib EPA, ICR Soy and the ICR EPA groups. The tumor free period of the ICR EPA group was significantly longer than all the other groups (ICR EPA vs Ad Lib Soy P Conclusions: These results illustrate that mammary tumor inhibition is significantly increased when ICR and EPA are combined as compared to either intervention alone or no intervention. It also identifies the NFκB pathway as a potential pathway of interest for inhibition of mammary tumor formation. Understanding how this pathway is affected may aid in the development of drugs that could be used for breast cancer prevention. Citation Information: Cancer Prev Res 2010;3(12 Suppl):B63.


Cancer Prevention Research | 2010

Abstract A110: Protective effect of intermittent calorie restriction on mammary tumor development despite high‐fat feeding

Olga P. Rogozina; Melissa J.L. Bonorden; Katai J. Nkhata; Joseph P. Grande; Margot P. Cleary

Intermittent caloric restriction (ICR) provides greater prevention of mammary tumor (MT) development than chronic caloric restriction (CCR). Here we assessed the impact of a high‐fat diet on this protective effect in relation to serum IGF‐I, leptin and adiponectin. At 10 wk of age MMTV‐TGF‐α female mice were assigned to AL (ad libitum 23% fat calories), ICR (3‐wk of 50% caloric restriction with 2× protein, fat, vitamins and minerals followed by 3‐wk of 100%AL mice9s consumption) and CCR (calorie/nutrient intake matched to ICR for each 6‐wk cycle) groups (n=45/group). Food intakes were determined daily. Body weights, MT palpation and MT measurements were done weekly. Mice were followed until MT burden necessitated euthanasia or they reached 79 (end of restriction) or 82 (end of refeeding) weeks of age. Serum samples were obtained at baseline, euthanasia and cycles 5, 8, and 11 during restriction and refeeding for ICR mice. Food intakes for ICR and CCR mice were 24.2% and 24.3% lower than AL mice (p ICR‐Restricted mice had significantly higher terminal serum IGFBP‐3 and lower IGF‐I and IGF‐1/IGFBP‐3 ratio than AL mice. There were no differences for CCR and ICR‐Refed mice compared to either AL or ICR‐Restricted groups. ICR‐Restricted mice had significantly lower serum leptin and significantly higher terminal adiponectin and adiponectin/leptin ratio compared to AL, CCR and ICR‐Refed mice. There were no differences in terminal serum measurements between mice with MTs versus those without MTs. IGF‐I of AL and CCR mice did not change with age whereas for ICR mice IGF‐1 was reduced during restriction periods. AL mice had the highest leptin levels across the study follow by CCR. For ICR mice leptin fluctuated in response to calorie intake, higher in refeeding vs restriction. Adiponectin levels for AL and CCR mice over time were similar. ICR mice had higher adiponectin levels when restricted vs refed. The adiponectin/leptin ratio of AL, CCR and ICR‐refed mice was dramatically lower across the study compared with baseline but for ICR‐restricted mice it was similar. These results indicate that ICR provides greater protection compared to CCR to prevent MT development even when a high fat diet is fed during refeeding. This was reflected by decreased MT incidence and MT burden and aggressiveness. Serum IGF‐I, adiponectin and leptin were significantly affected by periods of 50% restriction providing a milieu conducive to reduced MT development. Citation Information: Cancer Prev Res 2010;3(1 Suppl):A110.


Frontiers in Bioscience | 2009

Targeting the adiponectin: leptin ratio for postmenopausal breast cancer prevention

Margot P. Cleary; Amitabha Ray; Olga P. Rogozina; Soner Dogan; Michael E. Grossmann

Collaboration


Dive into the Olga P. Rogozina's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna Lokshin

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Soner Dogan

University of Minnesota

View shared research outputs
Researchain Logo
Decentralizing Knowledge